UNSPSC 51282100: Beta-lactams

This classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.

UNSPSC 51282100 Beta-lactams is a Class code that does not align with the recent state and local opportunities posted under it. The code nominally describes beta-lactam antibiotic pharmaceuticals, but the four most recent solicitations—covering naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, general medical and first aid supplies for fire rescue, and generic multi-source pharmaceuticals with over-the-counter products—show little relevant activity targeting beta-lactam antibiotics specifically. State and local issuing bodies using this code classification include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multi-jurisdictional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government). The scope of procurement under this code spans pharmaceutical procurement broadly—including opioid-reversal agents, pharmaceutical supply chain management, emergency medical supplies, and generic drug sourcing—rather than beta-lactam antibiotics as a discrete product line.

Geographically, the code shows recent activity in Florida, Texas, and Minnesota, with multi-state cooperative purchasing reaching Oregon and other participating jurisdictions. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies estimated at $700,000, sheltered for Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers. The code shows limited direct relevance to beta-lactam procurement activity.